Related references
Note: Only part of the references are listed.Lgr5 in cancer biology: functional identification of Lgr5 in cancer progression and potential opportunities for novel therapy
Liangliang Xu et al.
STEM CELL RESEARCH & THERAPY (2019)
LGR5 acts as a target of miR-340-5p in the suppression of cell progression and drug resistance in breast cancer via Wnt/β-catenin pathway
Shuai Shi et al.
GENE (2019)
G-Protein-Coupled Receptor 5 (LGR5) Overexpression Activates β-Catenin Signaling in Breast Cancer Cells via Protein Kinase
Zhishui Chen et al.
MEDICAL SCIENCE MONITOR BASIC RESEARCH (2019)
MMP9 modulates the metastatic cascade and immune landscape for breast cancer anti-metastatic therapy
Mark Owyong et al.
LIFE SCIENCE ALLIANCE (2019)
LGR5 overexpression confers poor relapse-free survival in breast cancer patients
Ming-Feng Hou et al.
BMC CANCER (2018)
Cancer Statistics, 2018
Rebecca L. Siegel et al.
CA-A CANCER JOURNAL FOR CLINICIANS (2018)
Recent Advances in Lgr5+ Stem Cell Research
Carly Leung et al.
TRENDS IN CELL BIOLOGY (2018)
Atezolizumab and Nab-Paclitaxel in Advanced Triple-Negative Breast Cancer
P. Schmid et al.
NEW ENGLAND JOURNAL OF MEDICINE (2018)
Identification of quiescent and spatially restricted mammary stem cells that are hormone responsive
Nai Yang Fu et al.
NATURE CELL BIOLOGY (2017)
Are Small Breast Cancers Good because They Are Small or Small because They Are Good?
Donald R. Lannin et al.
NEW ENGLAND JOURNAL OF MEDICINE (2017)
Lgr5 is a marker for fetal mammary stem cells, but is not essential for stem cell activity or tumorigenesis
Christy L. Trejo et al.
NPJ BREAST CANCER (2017)
Establishing estrogen-responsive mouse mammary organoids from single Lgr5+ cells
Lixing Zhang et al.
CELLULAR SIGNALLING (2017)
Breast-Cancer Tumor Size, Overdiagnosis, and Mammography Screening Effectiveness
H. Gilbert Welch et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
The hallmarks of premalignant conditions: a molecular basis for cancer prevention
Brid M. Ryan et al.
SEMINARS IN ONCOLOGY (2016)
The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
Vicki Plaks et al.
CELL STEM CELL (2015)
PIK3CAH1047R induces multipotency and multi-lineage mammary tumours
Shany Koren et al.
NATURE (2015)
Single-cell analysis reveals a stem-cell program in human metastatic breast cancer cells
Devon A. Lawson et al.
NATURE (2015)
Targeting LGR5+ cells with an antibody-drug conjugate for the treatment of colon cancer
Melissa R. Junttila et al.
SCIENCE TRANSLATIONAL MEDICINE (2015)
LGR5 Promotes Breast Cancer Progression and Maintains Stem-Like Cells Through Activation of Wnt/β-Catenin Signaling
Lu Yang et al.
STEM CELLS (2015)
Genomic differences between pure ductal carcinoma in situ and synchronous ductal carcinoma in situ with invasive breast cancer
Shinn Young Kim et al.
ONCOTARGET (2015)
How Many Etiological Subtypes of Breast Cancer: Two, Three, Four, Or More?
William F. Anderson et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2014)
p38MAPK Plays a Crucial Role in Stromal-Mediated Tumorigenesis
Elise Alspach et al.
CANCER DISCOVERY (2014)
Patient-Derived Xenograft Models: An Emerging Platform for Translational Cancer Research
Manuel Hidalgo et al.
CANCER DISCOVERY (2014)
Ductal Carcinoma In Situ of the Breast
Kalliopi P. Siziopikou
ARCHIVES OF PATHOLOGY & LABORATORY MEDICINE (2013)
Molecular subtypes in ductal carcinoma in situ of the breast and their relation to prognosis: a population-based cohort study
Wenjing Zhou et al.
BMC CANCER (2013)
Molecularly targeted therapies for metastatic triple-negative breast cancer
Soley Bayraktar et al.
BREAST CANCER RESEARCH AND TREATMENT (2013)
Addressing Overtreatment in Breast Cancer
Steven J. Katz et al.
CANCER (2013)
Lgr5-Expressing Cells Are Sufficient and Necessary for Postnatal Mammary Gland Organogenesis
Vicki Plaks et al.
CELL REPORTS (2013)
Developmental stage-specific contribution of LGR5+ cells to basal and luminal epithelial lineages in the postnatal mammary gland
Karin E. de Visser et al.
JOURNAL OF PATHOLOGY (2012)
Effect of Three Decades of Screening Mammography on Breast-Cancer Incidence
Archie Bleyer et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Monoclonal Antibodies Against Lgr5 Identify Human Colorectal Cancer Stem Cells
Kristel Kemper et al.
STEM CELLS (2012)
Lgr5+ve Stem/Progenitor Cells Contribute to Nephron Formation during Kidney Development
Nick Barker et al.
CELL REPORTS (2012)
Human tumors instigate granulin-expressing hematopoietic cells that promote malignancy by activating stromal fibroblasts in mice
Moshe Elkabets et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Breast cancer cells produce tenascin C as a metastatic niche component to colonize the lungs
Thordur Oskarsson et al.
NATURE MEDICINE (2011)
Tumor grafts derived from women with breast cancer authentically reflect tumor pathology, growth, metastasis and disease outcomes
Yoko S. DeRose et al.
NATURE MEDICINE (2011)
Lgr5+ve Stem Cells Drive Self-Renewal in the Stomach and Build Long-Lived Gastric Units In Vitro
Nick Barker et al.
CELL STEM CELL (2010)
Breast cancer precursors revisited: molecular features and progression pathways
Maria A. Lopez-Garcia et al.
HISTOPATHOLOGY (2010)
Triple-Negative Breast Cancer
William D. Foulkes et al.
NEW ENGLAND JOURNAL OF MEDICINE (2010)
Directed Therapy of Subtypes of Triple-Negative Breast Cancer
Lisa A. Carey
ONCOLOGIST (2010)
MOLECULAR ORIGINS OF CANCER Gene-Expression Signatures in Breast Cancer
Christos Sotiriou et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Genomic differences between pure ductal carcinoma in situ of the breast and that associated with invasive disease:: a calibrated aCGH study
Vladimir V. Iakovlev et al.
CLINICAL CANCER RESEARCH (2008)
How basal are triple-negative breast cancers?
Francois Bertucci et al.
INTERNATIONAL JOURNAL OF CANCER (2008)
Prognostic impact of tumour-specific HMG-CoA reductase expression in primary breast cancer
Signe Borgquist et al.
BREAST CANCER RESEARCH (2008)
Identification of stem cells in small intestine and colon by marker gene Lgr5
Nick Barker et al.
NATURE (2007)
Triple-negative breast cancer: Clinical features and patterns of recurrence
Rebecca Dent et al.
CLINICAL CANCER RESEARCH (2007)
Oncomine 3.0: Genes, pathways, and networks in a collection of 18,000 cancer gene expression profiles
Daniel R. Rhodes et al.
NEOPLASIA (2007)
Overdiagnosis and overtreatment of breast cancer - Progression of ductal carcinoma in situ: the pathological perspective
JL Jones
BREAST CANCER RESEARCH (2006)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE GASTROENTEROLOGY & HEPATOLOGY (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE ONCOLOGY (2005)
REporting recommendations for tumor MARKer prognostic studies (REMARK)
LM McShane et al.
NATURE CLINICAL PRACTICE UROLOGY (2005)
The natural history of low-grade ductal carcinoma in situ of the breast in women treated by biopsy only revealed over 30 years of long-term follow-up
ME Sanders et al.
CANCER (2005)
Outcome of patients with ductal carcinoma in situ untreated after diagnostic biopsy - Results from the Nurses' Health Study
LC Collins et al.
CANCER (2005)
Medical progress - Ductal carcinoma in situ of the breast
HJ Burstein et al.
NEW ENGLAND JOURNAL OF MEDICINE (2004)
The origins of estrogen receptor alpha-positive and estrogen receptor alpha-negative human breast cancer
DC Allred et al.
BREAST CANCER RESEARCH (2004)
Gene expression patterns of breast carcinomas distinguish tumor subclasses with clinical implications
T Sorlie et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2001)
Risk factors for recurrence and metastasis after breast-conserving therapy for ductal carcinoma-in-situ: Analysis of European organization for research and treatment of cancer trial 10853
N Bijker et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Molecular portraits of human breast tumours
CM Perou et al.
NATURE (2000)
The C3(1)/SV40 T-antigen transgenic mouse model of mammary cancer: ductal epithelial cell targeting with multistage progression to carcinoma
JE Green et al.
ONCOGENE (2000)
Share Paper
